Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
International Flavors & Fragrances
IFF
|
+$147M |
| 2 |
Broadcom
AVGO
|
+$140M |
| 3 |
Builders FirstSource
BLDR
|
+$117M |
| 4 |
Equinix
EQIX
|
+$99.7M |
| 5 |
ConocoPhillips
COP
|
+$82.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GameStop
GME
|
+$464M |
| 2 |
Chevron
CVX
|
+$257M |
| 3 |
Apple
AAPL
|
+$250M |
| 4 |
BMCH
BMC Stock Holdings, Inc
BMCH
|
+$197M |
| 5 |
CHL
China Mobile Limited
CHL
|
+$178M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.74% |
| 2 | Technology | 15.62% |
| 3 | Industrials | 13.76% |
| 4 | Consumer Discretionary | 12.2% |
| 5 | Healthcare | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Amneal Pharmaceuticals
AMRX
$5.85B
| $6.18M | ﹤0.01% |
917,707
+469,059
| +105% | +$2.6M |
|
|
PBPB
2502
DELISTED
Potbelly
PBPB
| $6.17M | ﹤0.01% |
1,043,493
-165,927
| -14% | -$889K |
|
2503
Transmedics
TMDX
$2.64B
| $6.13M | ﹤0.01% |
147,669
+125,823
| +576% | +$3.87M |
|
|
YELL
2504
DELISTED
Yellow Corporation Common Stock
YELL
| $6.08M | ﹤0.01% |
691,473
-59,950
| -8% | -$387K |
|
|
VNTR
2505
DELISTED
Venator Materials PLC
VNTR
| $6.08M | ﹤0.01% |
1,312,043
+137,236
| +12% | +$584K |
|
|
RNWK
2506
DELISTED
RealNetworks Inc
RNWK
| $6.04M | ﹤0.01% |
1,415,661
+44,958
| +3% | +$157K |
|
2507
Iovance Biotherapeutics
IOVA
$1.82B
| $6.04M | ﹤0.01% |
191,150
+52,425
| +38% | +$2.17M |
|
2508
Orrstown Financial Services
ORRF
$840M
| $6.04M | ﹤0.01% |
270,629
+17,706
| +7% | +$352K |
|
|
CBAY
2509
DELISTED
Cymabay Therapeutics
CBAY
| $6M | ﹤0.01% |
1,322,192
+70,206
| +6% | +$378K |
|
2510
Impinj
PI
$4.62B
| $5.99M | ﹤0.01% |
105,479
-153
| -0.1% | -$9.01K |
|
|
WSR
2511
DELISTED
Whitestone REIT
WSR
| $5.99M | ﹤0.01% |
617,251
-20,515
| -3% | -$184K |
|
2512
Nordic American Tanker
NAT
$1.38B
| $5.97M | ﹤0.01% |
1,837,229
-174,867
| -9% | -$564K |
|
2513
Aware
AWRE
$26M
| $5.96M | ﹤0.01% |
1,634,383
-27,023
| -2% | -$115K |
|
2514
10x Genomics
TXG
$6B
| $5.96M | ﹤0.01% |
32,946
+19,324
| +142% | +$3.34M |
|
2515
Fastly Inc
FSLY
$3.55B
| $5.95M | ﹤0.01% |
88,529
+9,310
| +12% | +$800K |
|
|
BPMC
2516
DELISTED
Blueprint Medicines
BPMC
| $5.95M | ﹤0.01% |
61,117
-5,745
| -9% | -$574K |
|
|
GBL
2517
DELISTED
GAMCO Investors, Inc.
GBL
| $5.93M | ﹤0.01% |
319,867
-26,119
| -8% | -$494K |
|
|
WBK
2518
DELISTED
Westpac Banking Corporation
WBK
| $5.92M | ﹤0.01% |
319,222
-8,845
| -3% | -$156K |
|
2519
Stantec
STN
$8.04B
| $5.9M | ﹤0.01% |
137,854
| – | – |
|
|
KALV
2520
DELISTED
KalVista Pharmaceuticals
KALV
| $5.87M | ﹤0.01% |
228,625
+22,108
| +11% | +$581K |
|
|
CVLY
2521
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $5.87M | ﹤0.01% |
318,960
+14,429
| +5% | +$251K |
|
2522
TransAlta
TAC
$3.95B
| $5.86M | ﹤0.01% |
619,200
-31,016
| -5% | -$275K |
|
2523
First Bank
FRBA
$464M
| $5.85M | ﹤0.01% |
479,873
+29,104
| +6% | +$315K |
|
|
ERF
2524
DELISTED
Enerplus Corporation
ERF
| $5.83M | ﹤0.01% |
1,163,254
-28,606
| -2% | -$126K |
|
|
KIN
2525
DELISTED
Kindred Biosciences, Inc.
KIN
| $5.83M | ﹤0.01% |
1,174,979
-13,906
| -1% | -$67.2K |
|
Similar funds
Dimensional Fund Advisors's Q1 2021 Portfolio in Review
As of Q1 2021, Dimensional Fund Advisors held 3,466 positions worth $302B, up 9.2% from $277B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Dimensional Fund Advisors's Q1 2021 filing shows 123 new, 1,208 increased, 1,942 reduced and 57 closed positions. Its largest new stake was Cognyte Software: 1,291,244 shares worth $35.9M. The largest sale was GameStop, an estimated $464M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.
- Dimensional Fund Advisors's largest Q1 2021 buy was Cognyte Software: 1,291,244 shares worth $35.9M.
- Dimensional Fund Advisors added most to International Flavors & Fragrances in Q1 2021, an estimated $147M increase.
- Dimensional Fund Advisors's biggest Q1 2021 reduction was GameStop, cutting an estimated $464M.
- Dimensional Fund Advisors fully exited BMC Stock Holdings, Inc in Q1 2021, selling an estimated $197M.
- Dimensional Fund Advisors's ten largest holdings make up 9.8% of its $302B portfolio in Q1 2021.
- Dimensional Fund Advisors opened 123 new positions and closed 57 in Q1 2021.
- Dimensional Fund Advisors's portfolio value rose 9.2% quarter-over-quarter to $302B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2021, filed 14 May 2021.